Terms & Conditions

NO WARRANTY

Information accessed through this website is presented in summary and interactive form and is not exhaustive. Sepracor Inc. makes no warranties or representations as to its accuracy or completeness. This information is provided "as is" without warranty of any kind, either express or implied, including but not limited to implied warranties of merchantability, fitness for particular purpose, or non-infringement. Some jurisdictions do not allow exclusion of implied warranties so the above exclusion may not apply to you. Certain links on this site lead to sites or sources located on servers maintained by third parties over which Sepracor has no control. Sepracor makes no representation as to the accuracy or any other aspect of the information contained in or on such sites, sources or servers, nor does Sepracor necessarily endorse such sites or sources. Neither Sepracor nor its affiliates or their respective employees shall be liable in any way for any legal claims, whether in contract, tort or otherwise in any way connected with the use or performance of this website or any information linked or referenced by this site or any other information or World Wide Web site which link to this site.

The information included in (or accessible from) this website contains forward-looking statements that involve risks and uncertainties, including statements with respect to the safety, efficacy, potential benefits, and successful development of the company's pharmaceuticals under development. Among the factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the submission, acceptance, and approval of regulatory filings; the results of clinical trials with respect to products under development; the scope of the company's patent protection with respect to such product candidates; the commercial success of Sepracor's products; the ability of the company to attract and retain qualified personnel; the performance of Sepracor's licensees; the availability of sufficient funds to continue research and development efforts; and certain other factors that may affect future operating results and are detailed in the company's periodic reports filed with the Securities and Exchange Commission.

NON-COMMERCIAL USE

Sepracor gives you permission to copy pages of www.ALVESCO.US documents published herein on the World Wide Web for non-commercial use only, provided any copy of these documents that you make shall retain all copyright and other proprietary notices and any disclaimers contained herein.

COPYRIGHTS/TRADEMARKS

All images, trademarks and text are the property of Sepracor Inc., unless otherwise indicated, and may not be downloaded, distributed, sorted, reused, reported, modified or otherwise used except as provided herein, without the express written permission of Sepracor Inc. All product and service names appearing in a typeface different from that of the surrounding text or with a trademark symbol, including "Sepracor" logo, are trademarks and service marks owned by Sepracor Inc. or its subsidiaries or affiliates or another company. Use of these marks, except as permitted herein, is expressly prohibited. Nothing contained herein shall be construed as conferring, by implication, estoppel or otherwise, any license or right under any patent or trademark of Sepracor or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right under any Sepracor copyright.

NO CONFIDENTIALITY

No confidential relationship shall be established in the event that any user of this World Wide Web site should make any oral, written or electronic response to Sepracor (such as feedback, questions, comments, suggestions, ideas, etc.). Such response and any information submitted therewith shall be considered non-confidential, and Sepracor shall be free to reproduce, publish or otherwise use such information for any purposes whatsoever including, without limitation, the research, development, manufacture, use or sale of products incorporating such information. The sender of any information to Sepracor is fully responsible for its content, including its truthfulness and accuracy and its non-infringement of any other person's proprietary rights.

INDIVIDUAL USAGE OF MEDICAL PRODUCTS

The information provided via this website concerning medical products is not complete and should not be used as a substitute for a consultation or visit with a physician or other healthcare provider. Should you have any healthcare related questions, please see your physician or other healthcare provider promptly.

Sepracor Inc. may, at any time, revise these Terms and Conditions by updating this page. You are bound by any such revisions and should therefore periodically visit this page to review the then current Terms and Conditions.

Start Saving Now
Register for the Instant Rebate Program

Activate Card
Activate your Instant Rebate Card

*Maximum benefit is $75 off, on up to 12 prescriptions/refills of ALVESCO per year. Not valid for patients participating in Medicare, Medicaid, government (public insurance) programs, and where prohibited by law. Click here for program rules.

INDICATION: ALVESCO is for the long-term treatment of asthma as preventative therapy in adults and adolescents 12 years of age and older.

IMPORTANT SAFETY INFORMATION

ALVESCO is NOT a rescue inhaler and should not be used for relief of sudden symptoms of shortness of breath during an asthma attack.  Use a fast-acting rescue medicine (such as a levalbuterol or albuterol inhaler) to relieve sudden symptoms if you have an asthma attack.  You should contact your healthcare professional if an asthma attack does not respond to your rescue medicine or you need to use your rescue medicine more often than usual.

You should not use ALVESCO if you are allergic to ciclesonide or any of the ingredients in ALVESCO.  Rare cases of severe allergic reactions, including swelling of the lips, tongue and throat, have been reported.

It is important to take ALVESCO regularly, as prescribed.  Do not stop treatment even if you are feeling better, unless told to do so by your healthcare professional.  You should contact your healthcare professional if your symptoms do not improve after 4 weeks, or if your condition worsens at any time during treatment.  DO NOT inhale more doses or use your ALVESCO inhaler more often than you have been directed.

Yeast infections of the mouth and throat (thrush) have occurred in some ALVESCO patients.  Rinse your mouth after you inhale each dose of ALVESCO.  If you develop a yeast infection, it should be treated by a healthcare professional.  Patients taking ALVESCO are at a possible increased risk of infection due to a weakened immune system that may occur when taking a steroid medicine.  Tell your healthcare professional if you have had tuberculosis (TB) or any other infections before or while using ALVESCO, or if you are exposed to chickenpox or measles.

If you took an oral (by mouth) steroid previously and are having the dose decreased, or you have been switched to ALVESCO from an oral steroid, tell your healthcare professional right away about any symptoms such as feeling tired or exhausted, weakness, nausea, vomiting, or symptoms of low blood pressure (such as dizziness or faintness).  These may be symptoms of a potentially life-threatening condition in which your body does not produce enough natural steroids.

Using inhaled steroid medicines for a long time may put you at greater risk for decreased bone mass (which can cause bones to become weaker).  Inhaled corticosteroids including ALVESCO may cause slowed growth in children and adolescents.  Your healthcare professional should monitor your bone health and the growth of children and adolescents taking ALVESCO. 

As with other inhaled asthma medicines, bronchospasm (a sudden squeezing of the airways) can occur, with wheezing, right after you inhale your dose of ALVESCO.  If this happens, stop using ALVESCO and use a rescue medicine right away, such as levalbuterol or albuterol.  You should also inform your healthcare professional right away so that your asthma medicine can be re-evaluated.

The most common side effects with ALVESCO include headache, pain or irritation of the nose and throat, sinus infection, upper respiratory infection (such as the common cold), joint pain, stuffy nose, leg pain, and back pain.

For additional information, please see the full Prescribing Information for ALVESCO.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Prescribing InformationPatient Instructions for UseSitemapPrivacy StatementTerms & ConditionsMedical DisclaimerUnsubscribe

 

and SEPRACOR are registered trademarks of Sepracor Inc. ALVESCO is a registered trademark of Nycomed GmbH, used with permission.